Connect with us

Impact Investing

Verdalia Bioenergy Buys 7 Biomethane Plants from Green Arrow Capital and Lazzari&Lucchini

Verdalia Bioenergy, launched by Goldman Sachs, acquired seven biomethane plants in Brescia from Green Arrow Capital and Lazzari & Lucchini. These plants produce 190 GWh of biomethane annually, eliminating 65,000 tons of greenhouse gas emissions. The acquisition supports Verdalia’s European expansion, leveraging Italy’s supportive regulatory framework for decarbonization and renewable energy incentives.



verdalia bioenergy

Verdalia Bioenergy, a platform launched by Goldman Sachs in February 2023 to invest over a billion euros in Europe in the biomethane sector by 2026, has acquired a portfolio of 7 operating plants in the Brescia area for the production of biomethane from funds controlled by Green Arrow Capital and Lazzari & Lucchini, a company specialized in the production of energy from renewable and sustainable sources.

The portfolio bought by Verdalia Bioenergy consists of plants with a total production capacity of approximately 190 GWh

In the operation, Green Arrow and L&L were assisted by MFZ (financial advisor), Parola & Associati (legal and regulatory aspects) while Verdalia Bioenergy was supported by Intesa Sanpaolo (for the M&A aspects), by Ashurst (for the legal aspects), by EY (for the financial and fiscal part), by Ramboll (in the technical field) and by ERM (for environmental issues).

The portfolio consists of plants with a total production capacity of approximately 190 GWh of biomethane deriving from the treatment of 350 thousand tonnes of raw materials per year, with the possibility of expanding these volumes by over 50%. The plants have come into operation over the last few years and aim to eliminate approximately 65 thousand tons of greenhouse gas emissions per year. The construction of the assets is part of the partnership, started in 2020, which now aims to double the number of plants with a second portfolio of at least six assets , which will come into operation by 2025.

The entire portfolio of these first 7 plants produces biomethane thanks to the sole recovery of livestock effluents and agricultural by-products not intended for human consumption. During 2023, the last four of the seven plants were put into operation and, last December, the project financing of the entire portfolio was finalized.

The seven plants bought by Verdalia Bioenergy, built and financed between 2020 and 2023, are incentivized pursuant to the Ministerial Decree “Biomethane 2018”, which represented a significant step towards the promotion of renewable energy in the Italian energy sector, establishing incentives and regulations to encourage the production and use of biomethane.

In detail, the last four plants inaugurated in March were: Bio Gottolengo Solaro and CH4 Gottolengo, both located in Gottolengo; Bio Sole, located in Montichiari; and Gambaresca in Verolanuova. The three that have already been operational for some time are Bio Tre Ponti, located in Borgo San Giacomo; Bio Industria, with production of BIOGNL, and Bio Verola, both in Verolanuova.

The acquisition of the latter portfolio therefore strengthens Verdalia Bioenergy’s presence in Europe in the biomethane sector on the continent, building on an infrastructure business model . All plants benefit from the incentive program established by the Ministerial Decree of 2 March 2018 and the feedstock is guaranteed through medium-long term supply contracts.

Fernando Bergasa, president and CEO of Verdalia Bioenergy, commented: “We believe that Italy is at the forefront of the European decarbonization program through biomethane, which is based on a supportive regulatory framework , and we are proud to actively contribute to the plan energy transition of the country through this important investment.”

Matteo Botto Poala, managing director of Goldman Sachs Asset Management’s infrastructure investment business, added: “We are very happy with the progress made by Verdalia which, once again, is testament to Goldman Sachs Asset Management’s track record in being a pioneer in investments for the energy transition and in the development of successful platforms. We look forward to continuing to invest in European biomethane and attracting new talent to join Verdalia’s world-class management team.”

Matteo Grandi, country manager of Verdalia Italia, concluded: “Green Arrow and L&L have developed 7 high-level biomethane plants. The acquisition of these plants represents an important starting point to launch our activities in Italy and we look to the future with optimism, continuing to work on our expansion in the country.”

Verdalia Bioenergy had conducted its first investment in Spain

Grandi, previously responsible for agricultural and agri-industrial biomethane at Snam and previously at Ladurner, was appointed last September to lead the development of Verdalia Bioenergy Italia’s activities, at the same time as the announcement of the company’s entry into the Italian market. Verdalia Bioenergy had conducted its first investment in Spain, coinciding with the launch of the platform in early 2023, relating to a portfolio of biomethane projects in intermediate development, with a total capacity of approximately 150 GWh/year.

Since then the company has made significant progress and now has a team of 50 people and a pipeline of mid-to-late-stage development projects in Spain and Italy with a volume of over 2.5 TWh of biomethane per year. As explained in a note from the company, Verdalia Bioenergy will continue to pursue new expansion opportunities through the acquisition of brownfield and greenfield projects , establishing partnerships with EPCs and long-term agreements with offtakers and feedstock suppliers, also thanks to the strengthening of its team.


(Featured image by Julia Koblitz via Unsplash)

DISCLAIMER: This article was written by a third party contributor and does not reflect the opinion of Born2Invest, its management, staff or its associates. Please review our disclaimer for more information.

This article may include forward-looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this article and on this site. Although the Company may believe that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof. Additionally, please make sure to read these important disclosures.

First published in StartupItalia. A third-party contributor translated and adapted the article from the original. In case of discrepancy, the original will prevail.

Although we made reasonable efforts to provide accurate translations, some parts may be incorrect. Born2Invest assumes no responsibility for errors, omissions or ambiguities in the translations provided on this website. Any person or entity relying on translated content does so at their own risk. Born2Invest is not responsible for losses caused by such reliance on the accuracy or reliability of translated information. If you wish to report an error or inaccuracy in the translation, we encourage you to contact us

Jeremy Whannell loves writing about the great outdoors, business ventures and tech giants, cryptocurrencies, marijuana stocks, and other investment topics. His proficiency in internet culture rivals his obsession with artificial intelligence and gaming developments. A biker and nature enthusiast, he prefers working and writing out in the wild over an afternoon in a coffee shop.